Fortrea (FTRE) has completed its debt tender offer described in the Offer to Purchase dated October 20, 2025 by purchasing $75,743,000 in aggregate of the Company’s outstanding 7.500% Senior Secured Notes due 2030. The Tender Offer to repurchase of a portion of the Notes satisfied a requirement relating to the Company’s divestiture of its Fortrea Patient Access and Endpoint Clinical businesses completed in June 2024. Fortrea’s purchase of the tendered Notes on November 21, 2025, reduced the principal outstanding on the Notes from $570,000,000 to $494,257,000. According to U.S. Bank Trust Company, National Association, as tender agent for the Tender Offer, the aggregate principal amount of Notes validly tendered and not validly withdrawn on or before the expiration date exceeded $75,744,000. In accordance with the terms and conditions of the Tender Offer, the Company accepted for purchase $75,743,000 in aggregate principal amount of the Notes validly tendered, based on a Final Proration Factor of 0.154199 and after rounding down to the nearest $1,000 principal amount.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE:
- Fortrea Holdings Completes Oversubscribed Debt Tender Offer
- Fortrea appoints Gallagher as General Counsel
- Starboard takes new stake in Bill Holdings, exits Pfizer position
- Cautious Outlook for Fortrea Holdings Inc. Amid 2026 Challenges and Potential 2027 Recovery
- Fortrea price target raised to $12 from $10 at Citi